乙粉稳定型多聚烯具有高热增强释放和催化活性,用于协同抗瘤疗法
Xiaoyun Huang1,2, Zhiming Liu3, Weijian Zeng4
1School of Clinical Medicine, Qujing Medical College Qujing 655100 Yunnan China hhuo0010@163.com.
RSC advances
|March 13, 2024
概括
这项研究开发了一种安全的芬顿催化疗法,用于用于癌症治疗的粉化聚烯纳米颗粒. 这些纳米颗粒产生有毒的基基,并释放化疗药物,增强瘤细胞的杀死,副作用最小.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
背景情况:
- 芬顿催化疗法为癌症治疗提供了一种有前途的方法,通过产生基激素 (·OH) 来治疗氧化损伤.
- 由于与未经批准的成分相关的生物安全问题,芬顿药物的临床转化受到阻碍.
- 现有的疗法往往需要外部能量输入或氧气,限制了它们的适用性.
研究的目的:
- 为癌症治疗开发一种安全有效的芬顿催化剂治疗剂.
- 克服目前基于芬顿的治疗方法的生物安全局限性.
- 通过催化疗,化疗和高温疗法的结合来增强瘤细胞杀伤.
主要方法:
- 在合成基于铜的聚烯纳米颗粒中使用安全认可的粉作为稳定剂.
- 用多克索鲁比辛 (DOX) 装载纳米颗粒,以创建含有DOX的基多聚烯 (HES@CuP-D) 的基多聚烯 (HES@CuP-D).
- 研究了HES@CuP-D在过氧化 (H2O2) 存在下的催化活性,并评估了激光照射的影响.
主要成果:
- HES@CuP-D通过Cu+介导的芬顿式反应有效地催化了瘤细胞内的内源H2O2产生的OH的产生.
- 生成的OH诱导了纳米颗粒的氧化损伤和结构崩,导致受控的DOX释放.
- 使用HES@CuP-D和激光照射的联合治疗通过协同热量和加速药物释放来增强瘤杀伤.
结论:
- 开发的HES@CuP-D纳米粒子为芬顿催化疗法提供了一个有前途的策略,其生物安全性得到了改善.
- 氧化损伤和化疗的双重作用机制提高了抗瘤疗效.
- 这种方法为晚期癌症治疗药物提供了可行的临床转化途径,系统毒性可忽略不计.
更多相关视频
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


